Denmark’s Biotech Industry in Europe’s Top 3
A new report from Ernst & Young shows that Danish biotech is growing rapidly, both in terms of drugs in development and capital raised. Denmark ranks 3rd in Europe in terms of number of biotech products under development. Danish biotech companies shot up 25% from 2006 to 2007, compared with the European average of 9%.
And with 188 potential new products in the development pipeline, for diseases including HIV and cancer, Denmark is only headed in volume terms by Great Britain and Germany – both far bigger countries in size and population.